Clarivate names three GLP-1 researchers to 2026 Citation Laureates list
The annual citation analysis, often read as a Nobel bellwether, also recognized gene editing work this year.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 17 09:00 ETSource: BioWorld News
The wire
- 01Clarivate plc named three key GLP-1 researchers among its Citation Laureates 2026, BioWorld reported, alongside honorees in gene editing.
- 02The recognition tracks the widening research base for incretin peptides as indications expand beyond metabolic disease.
- 03BioWorld's item does not name the individual laureates in the excerpt available; Citation Laureate status carries no regulatory or commercial consequence.
From the source
Read at bioworld.comGLP-1s, gene editing make 2026 Citation Laureates list
Even as the treatment potential for GLP-1 drugs continues to expand beyond metabolic indications, recognition grows for the scientific breakthroughs that led to the blockbuster peptide hormone, with Clarivate plc naming three key GLP-1 researchers among its Citation Laureates 2026.